Neutoin 23 mg (Donepezil Hydrochloride Hydrate)

Adult dose

This medication should be taken once daily before bedtime, regardless of food. The initial recommended dose of Donepezil Hydrochloride is 5 mg once a day. For 4 to 6 weeks, 5 mg should be administered, during which clinical responses should be evaluated, and the dose may be increased to 10 mg. If increasing to 10 mg daily, it should be done with caution regarding gastrointestinal adverse reactions. Minimum duration of treatment should be 3 months.

This medication contains Donepezil Hydrochloride Hydrate as the active ingredient for the treatment of Alzheimer's-type dementia symptoms. It should not be used by patients with allergic reactions to Donepezil Hydrochloride, piperidine derivatives, or components of the medication, as well as pregnant or breastfeeding women, and patients with genetic issues like lactose intolerance. Patients with heart disease or a history of peptic ulcers, those with asthma or chronic obstructive pulmonary disease, and patients with extrapyramidal disorders such as Parkinson's disease should exercise special caution when using this medication. This medication may cause severe side effects such as bradycardia, arrhythmia, gastrointestinal bleeding, liver function abnormalities, cerebrovascular problems, and muscular abnormalities, so if any abnormal symptoms occur, immediate consultation with a physician is necessary. Common side effects such as nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headache, and fatigue may also occur, and care should be taken. This medication is not approved for other types of dementia or memory disorders aside from Alzheimer's-type dementia and should only be used under the diagnosis and supervision of an experienced physician. Patients with heart disease or electrolyte imbalances, those with a history of peptic ulcers, and those with asthma or pulmonary conditions need regular check-ups while taking this medication. Pregnant or breastfeeding women are advised not to use this medication and should only consider it after consulting a physician if necessary. The safety of this medication in children has not been established, so its use is not recommended. There may be interactions with other medications, so patients taking CYP3A4 inhibitors or inducers, anticholinergic medications, or cardiovascular drugs should inform their physician. In the event of overdose, severe symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, requiring immediate emergency treatment, and atropine may be used as an antidote. This medication should be stored out of reach of children, and care should be taken not to change the container, as it may adversely affect quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by coughing and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

Nausea, vomiting, diarrhea, loss of appetite, headache, fatigue, lethargy, dizziness, insomnia, hallucinations, agitation, aggressive behavior, drowsiness, anxiety, tremors, gait disturbances, involuntary movements, decreased concentration, mental dullness, thrombocytopenia, petechiae, eczema, itching, rash, incontinence, frequent urination, increased blood pressure, weight loss, dehydration, muscle pain, muscle cramps, urinary retention, blood system abnormalities (anemia, leukopenia, decreased hematocrit), palpitations

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and prevent deterioration.

Appearance

Brownish-red, biconvex, round film-coated tablet

Package unit

30 tablets/bottle